Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MECANO renal transplant maintenance immunosuppression study
NL-OMON25640Active, not recruiting
- Sponsor
- MECANO Steering group Chair: S.Surachno/F.Bemelman
- Start
- Jan 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial in kidney transplant immunosuppression and Transplant Nephropathy comparing Prednisolone + AUC-guided ciclosporin, Prednisolone + AUC-guided mycophenolate sodium and Prednisolone + AUC-guided everolimus (3 arms). Primary endpoint: Renal allograft histology. Started Jan 2004; status: active, not recruiting.
02
Drugs
cyclosporinemycophenolate sodiumeverolimusprednisolone
03
Conditions
kidney transplant immunosuppressionTransplant Nephropathy
Beyond the preview
Go deeper on NL-OMON25640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25640.